View in EDS

Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia.

Saved in:
Bibliographic Details
Title: Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia.
Authors: Branagan AR; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Mo C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lei M; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Gustine JN; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Yee AJ; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., O'Donnell E; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Castillo JJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Nadeem O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Flynn C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Bernstein Z; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Nakamoto-Matsubara R; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Meid K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Verma R; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Hunter ZR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Guerrera ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Alter G; Division of Medical Sciences, Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA., Burke J; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Harrington C; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Agyemang E; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Gammon M; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Lively K; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Packer L; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Horick N; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Laubach J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Mitsiades CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Munshi N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Anderson KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Treon SP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Richardson PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Raje NS; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA., Sarosiek SR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Source: Blood advances [Blood Adv] 2025 Sep 23; Vol. 9 (18), pp. 4568-4579.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40472329
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Branagan+AR%22">Branagan AR</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Mo+C%22">Mo C</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Lei+M%22">Lei M</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Gustine+JN%22">Gustine JN</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Yee+AJ%22">Yee AJ</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22O'Donnell+E%22">O'Donnell E</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Castillo+JJ%22">Castillo JJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Nadeem+O%22">Nadeem O</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Flynn+C%22">Flynn C</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Bernstein+Z%22">Bernstein Z</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Nakamoto-Matsubara+R%22">Nakamoto-Matsubara R</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Meid+K%22">Meid K</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Verma+R%22">Verma R</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Hunter+ZR%22">Hunter ZR</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Guerrera+ML%22">Guerrera ML</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Alter+G%22">Alter G</searchLink>; Division of Medical Sciences, Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Burke+J%22">Burke J</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Harrington+C%22">Harrington C</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Agyemang+E%22">Agyemang E</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Gammon+M%22">Gammon M</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Lively+K%22">Lively K</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Packer+L%22">Packer L</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Horick+N%22">Horick N</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Laubach+J%22">Laubach J</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Mitsiades+CS%22">Mitsiades CS</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Munshi+N%22">Munshi N</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Anderson+KC%22">Anderson KC</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Treon+SP%22">Treon SP</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Richardson+PG%22">Richardson PG</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Raje+NS%22">Raje NS</searchLink>; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Sarosiek+SR%22">Sarosiek SR</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2025 Sep 23; Vol. 9 (18), pp. 4568-4579.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40472329
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2025016513
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4568
    Titles:
      – TitleFull: Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Branagan AR
      – PersonEntity:
          Name:
            NameFull: Mo C
      – PersonEntity:
          Name:
            NameFull: Lei M
      – PersonEntity:
          Name:
            NameFull: Gustine JN
      – PersonEntity:
          Name:
            NameFull: Yee AJ
      – PersonEntity:
          Name:
            NameFull: O'Donnell E
      – PersonEntity:
          Name:
            NameFull: Castillo JJ
      – PersonEntity:
          Name:
            NameFull: Nadeem O
      – PersonEntity:
          Name:
            NameFull: Flynn C
      – PersonEntity:
          Name:
            NameFull: Bernstein Z
      – PersonEntity:
          Name:
            NameFull: Nakamoto-Matsubara R
      – PersonEntity:
          Name:
            NameFull: Meid K
      – PersonEntity:
          Name:
            NameFull: Verma R
      – PersonEntity:
          Name:
            NameFull: Hunter ZR
      – PersonEntity:
          Name:
            NameFull: Guerrera ML
      – PersonEntity:
          Name:
            NameFull: Alter G
      – PersonEntity:
          Name:
            NameFull: Burke J
      – PersonEntity:
          Name:
            NameFull: Harrington C
      – PersonEntity:
          Name:
            NameFull: Agyemang E
      – PersonEntity:
          Name:
            NameFull: Gammon M
      – PersonEntity:
          Name:
            NameFull: Lively K
      – PersonEntity:
          Name:
            NameFull: Packer L
      – PersonEntity:
          Name:
            NameFull: Horick N
      – PersonEntity:
          Name:
            NameFull: Laubach J
      – PersonEntity:
          Name:
            NameFull: Mitsiades CS
      – PersonEntity:
          Name:
            NameFull: Munshi N
      – PersonEntity:
          Name:
            NameFull: Anderson KC
      – PersonEntity:
          Name:
            NameFull: Treon SP
      – PersonEntity:
          Name:
            NameFull: Richardson PG
      – PersonEntity:
          Name:
            NameFull: Raje NS
      – PersonEntity:
          Name:
            NameFull: Sarosiek SR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 09
              Text: 2025 Sep 23
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 18
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1